Bacterial Endotoxin Testing: LAL Methods Explained

Bacterial endotoxin testing (BET) detects and quantifies endotoxin, the lipopolysaccharide from the outer membrane of Gram-negative bacteria, using Limulus amoebocyte lysate (LAL) or a recombinant alternative. It is the standard release test for pyrogenic contamination in injectables, water for injection and many medical devices.

Endotoxin survives ordinary sterilisation, so a sterile product can still cause fever or shock. That is why BET appears in almost every parenteral specification, and why inspectors check how the method was set up for each product.

What endotoxin is and why it matters

Endotoxin is released when Gram-negative bacteria grow or die, so water systems, raw materials and equipment are common sources. The lipid A part drives the pyrogenic response. Because steam sterilisation does not destroy it, depyrogenation relies on validated dry heat or on removal steps such as rinsing and ultrafiltration.

Results are expressed in endotoxin units (EU), calibrated against a reference standard endotoxin.

The pharmacopoeial framework

The bacterial endotoxins test is harmonised across USP <85>, Ph. Eur. 2.6.14 and the Japanese Pharmacopoeia. They cover gel-clot and photometric techniques, preparatory testing, interfering factors and maximum valid dilution. Ph. Eur. 5.1.10 adds guidance on applying the test.

Ph. Eur. added chapter 2.6.32, a test using recombinant factor C (rFC), as an animal-free alternative to horseshoe crab lysate. The position in the USP has been evolving, so check the current USP chapters and your regulator's expectations before using rFC for release testing, including whether you need to validate it as an alternative method.

How the LAL methods work

LAL is an extract of horseshoe crab blood cells. Endotoxin activates a clotting cascade that starts with factor C and ends with a gel. The methods differ in how they read it.

• Gel-clot: tubes are incubated and inverted. A firm gel that holds is positive. The limit test gives pass or fail against the labelled lysate sensitivity, called lambda (λ).
• Kinetic turbidimetric: a reader measures how fast turbidity develops. Time to reach a threshold is inversely related to endotoxin concentration.
• Kinetic chromogenic: a synthetic substrate releases a yellow colour as the cascade proceeds, read continuously.
• Endpoint chromogenic: the colour reaction is stopped after a fixed time and absorbance is read once.

LAL also contains a factor G pathway that responds to (1→3)-β-D-glucans from cellulose filters or some raw materials, which can give falsely high results. Glucan-blocking buffers or rFC, which lacks factor G, avoid this.

USP <85> states that in case of doubt or dispute the final decision is based on the gel-clot limit test, unless the monograph indicates otherwise.

Endotoxin limits: the K/M concept

For parenteral products, the endotoxin limit is calculated as K/M. K is the threshold pyrogenic dose, commonly 5.0 EU/kg for parenteral routes other than intrathecal and 0.2 EU/kg for intrathecal use. M is the maximum recommended bolus dose of product per kg of body mass in one hour. Many monographs already state a limit, and you should use it where one exists.

Water for injection has a pharmacopoeial endotoxin limit of less than 0.25 EU/mL in both Ph. Eur. and USP. Check the current monograph for your market.

Maximum valid dilution and interference testing

Many products inhibit or enhance the reaction, so you dilute them. The maximum valid dilution (MVD) is the greatest dilution at which the limit can still be detected:

• MVD = (endotoxin limit × concentration of test solution) / λ
• λ is the labelled lysate sensitivity for gel-clot, or the lowest point of the standard curve for photometric methods
• where the limit is per mL, the concentration term is 1.0 mL/mL

Interference testing shows that the product does not affect the result at your chosen dilution. For photometric methods, a positive product control (PPC) is spiked with a known amount of endotoxin, and recovery must be within 50% to 200%. For gel-clot, the geometric mean endpoint of spiked samples must fall within 0.5λ to 2λ. If recovery fails, dilute further within the MVD or apply a validated treatment, then retest.

Low endotoxin recovery

Low endotoxin recovery (LER) is the loss of detectable endotoxin when it is spiked into undiluted product and held over time. It has been reported mainly in some biologic formulations with chelating buffers and polysorbates. A standard PPC will not reveal it, so hold-time spike studies are expected where LER is plausible.

Worked example: WFI and an injectable at a Gujarat plant

A small-volume parenteral plant in Gujarat sets up kinetic chromogenic testing for two samples: WFI from its distribution loop, and a finished injectable containing 50 mg/mL of active ingredient with a maximum dose of 5 mg/kg per hour. The standard curve runs from 0.005 to 50 EU/mL.

WFI. The limit is less than 0.25 EU/mL and samples are tested undiluted. PPC recovery is 92% and routine results are below 0.005 EU/mL. An internal alert level below the limit catches early deterioration of the system.

Finished product. The team calculates the limit and MVD:

1. Endotoxin limit = K/M = 5.0 EU/kg ÷ 5 mg/kg = 1.0 EU/mg.
2. MVD = (1.0 EU/mg × 50 mg/mL) ÷ 0.005 EU/mL = 10,000.
3. Interference test at 1:10 gives PPC recovery of 31%, which fails. At 1:40, recovery is 88% and passes.
4. Three batches tested at 1:40 give results below 0.005 EU/mL in the diluted sample, which is less than 0.2 EU/mL in the product, or less than 0.004 EU/mg.
5. That is far below the 1.0 EU/mg limit, and 1:40 is well within the MVD, so the method is suitable.

Because the formulation contains a citrate buffer and polysorbate 80, QC also runs a hold-time LER study before approving the method. The suitability report, dilution and LER data are approved before routine use. The same principles of demonstrating fitness for purpose apply as in method validation vs verification.

Common mistakes

• Testing at a dilution that exceeds the MVD, so the method could not detect a failing batch.
• Never repeating interference testing after formulation or supplier changes.
• Using cellulose-based filters or materials that release glucans, giving false positives.
• Ignoring hold times between sampling and testing, especially for products at risk of LER.
• Switching to rFC without checking regulatory acceptance for the target market.

Key takeaway: A valid endotoxin result depends on three numbers set correctly for each product: the K/M limit, a test dilution within the MVD, and PPC recovery between 50% and 200%.

Frequently Asked Questions

What is the difference between endotoxin and pyrogen testing?

Endotoxin is one type of pyrogen, from Gram-negative bacteria. The bacterial endotoxins test detects only endotoxin. Pyrogen tests such as the rabbit pyrogen test or the monocyte activation test detect a wider range of fever-causing substances, including non-endotoxin pyrogens. Which test applies depends on the product, the monograph and the regulator, so check the requirements for your market.

Which LAL method is best?

No single method suits every product. Gel-clot is simple and is the referee method, but gives limited information. Kinetic chromogenic offers high sensitivity and supports trending, while kinetic turbidimetric suits some coloured products. The best choice is the method that passes interference testing for your product at a dilution within the MVD and fits your workload.

What is the endotoxin limit for water for injection?

Both the Ph. Eur. and USP monographs for water for injection set a bacterial endotoxin limit of less than 0.25 EU/mL. Most sites also set internal alert and action levels below this to detect deterioration in the water system early. Always check the current monograph for the markets you supply, as requirements and test methods can be revised.

Is recombinant factor C accepted by regulators?

Ph. Eur. includes rFC in chapter 2.6.32, so it is recognised for Ph. Eur. markets. In the USP, the position has been evolving, and some regulators still expect rFC to be validated as an alternative method. Before switching, check the current USP chapters, discuss with your regulatory affairs team and confirm what your target markets, including GCC authorities, will accept.

Next steps

If you work in QC microbiology or sterile manufacturing, our Pharmaceutical Microbiology & Contamination Control course covers endotoxin testing, water systems and contamination control. For related reading, see cleanroom environmental monitoring: grades A to D and method validation vs verification explained. You can also speak to a counsellor about the right course for your role.